Search research articles
Contact Us
Filters
Showing results (51-60 of 213) with videos related to
Page
of 22
Sort By:
Pharmacogenomics
|
November 20, 2002
Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer
Carme Sarries, Eric B Haura, Barbara Roig, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 10, 2021
Synthesis and structural characterization of a monocarboxylic inhibitor for GRB2 SH2 domain
Tao Xiao, Luxin Sun, Min Zhang, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
December 14, 2011
Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer
Mark G Alexandrow, Lanxi J Song, Soner Altiok, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 13, 2014
Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer
Lanxi Song, Matthew A Smith, Parul Doshi, et al.
Plos One
|
October 27, 2010
Characterizing tyrosine phosphorylation signaling in lung cancer using SH2 profiling
Kazuya Machida, Steven Eschrich, Jiannong Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 6, 2011
Intranuclear delivery of a novel antibody-derived radiosensitizer targeting the DNA-dependent protein kinase catalytic subunit
Hairong Xiong, Robert J Lee, Eric B Haura, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 24, 2011
An essential role for Stat3 in regulating IgG immune complex-induced pulmonary inflammation
Huifang Tang, Chunguang Yan, Jay Cao, et al.
Journal of Proteome Research
|
October 16, 2010
Using iTRAQ combined with tandem affinity purification to enhance low-abundance proteins associated with somatically mutated EGFR core complexes in lung cancer
Eric B Haura, André Müller, Florian P Breitwieser, et al.
Bioinformatics (Oxford, England)
|
October 10, 2008
IPEP: an in silico tool to examine proteolytic peptides for mass spectrometry
Dihui Lu, Richard Z Liu, Victoria Izumi, et al.
Scientific Reports
|
April 29, 2017
Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer
Andrew Dhawan, Daniel Nichol, Fumi Kinose, et al.
Page
of 22
Search research articles
Search
Showing results (51-60 of 213) with videos related to
Sort By:
Page
of 22
Pharmacogenomics
|
November 20, 2002
Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer
Carme Sarries, Eric B Haura, Barbara Roig, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 10, 2021
Synthesis and structural characterization of a monocarboxylic inhibitor for GRB2 SH2 domain
Tao Xiao, Luxin Sun, Min Zhang, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
December 14, 2011
Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer
Mark G Alexandrow, Lanxi J Song, Soner Altiok, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 13, 2014
Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer
Lanxi Song, Matthew A Smith, Parul Doshi, et al.
Plos One
|
October 27, 2010
Characterizing tyrosine phosphorylation signaling in lung cancer using SH2 profiling
Kazuya Machida, Steven Eschrich, Jiannong Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 6, 2011
Intranuclear delivery of a novel antibody-derived radiosensitizer targeting the DNA-dependent protein kinase catalytic subunit
Hairong Xiong, Robert J Lee, Eric B Haura, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 24, 2011
An essential role for Stat3 in regulating IgG immune complex-induced pulmonary inflammation
Huifang Tang, Chunguang Yan, Jay Cao, et al.
Journal of Proteome Research
|
October 16, 2010
Using iTRAQ combined with tandem affinity purification to enhance low-abundance proteins associated with somatically mutated EGFR core complexes in lung cancer
Eric B Haura, André Müller, Florian P Breitwieser, et al.
Bioinformatics (Oxford, England)
|
October 10, 2008
IPEP: an in silico tool to examine proteolytic peptides for mass spectrometry
Dihui Lu, Richard Z Liu, Victoria Izumi, et al.
Scientific Reports
|
April 29, 2017
Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer
Andrew Dhawan, Daniel Nichol, Fumi Kinose, et al.
Page
of 22